NO985791L - Enhet for transdermal administrering av trimegeston, fremgangsmÕte for fremstilling av enheten og anvendelse av denne som medikament - Google Patents

Enhet for transdermal administrering av trimegeston, fremgangsmÕte for fremstilling av enheten og anvendelse av denne som medikament

Info

Publication number
NO985791L
NO985791L NO985791A NO985791A NO985791L NO 985791 L NO985791 L NO 985791L NO 985791 A NO985791 A NO 985791A NO 985791 A NO985791 A NO 985791A NO 985791 L NO985791 L NO 985791L
Authority
NO
Norway
Prior art keywords
trimegestone
drug
preparation
transdermal administration
transdermal
Prior art date
Application number
NO985791A
Other languages
English (en)
Other versions
NO315149B1 (no
NO985791D0 (no
Inventor
Jean-Luc Dubois
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO985791D0 publication Critical patent/NO985791D0/no
Publication of NO985791L publication Critical patent/NO985791L/no
Publication of NO315149B1 publication Critical patent/NO315149B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19985791A 1996-06-11 1998-12-10 Adhesiv polymermatriks applisert på en enhet for transdermal administreringav en progestomimetisk forbindelse, enhet for transdermaladministrering av enprogestomimetrisk forbindelse og fremgangsmåte for fremstilling avenheten NO315149B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607208A FR2749586B1 (fr) 1996-06-11 1996-06-11 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
PCT/FR1997/001023 WO1997047333A1 (fr) 1996-06-11 1997-06-10 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone

Publications (3)

Publication Number Publication Date
NO985791D0 NO985791D0 (no) 1998-12-10
NO985791L true NO985791L (no) 1999-02-11
NO315149B1 NO315149B1 (no) 2003-07-21

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985791A NO315149B1 (no) 1996-06-11 1998-12-10 Adhesiv polymermatriks applisert på en enhet for transdermal administreringav en progestomimetisk forbindelse, enhet for transdermaladministrering av enprogestomimetrisk forbindelse og fremgangsmåte for fremstilling avenheten

Country Status (23)

Country Link
EP (1) EP0906127B1 (no)
JP (1) JP2000514416A (no)
CN (1) CN1110327C (no)
AR (1) AR013580A1 (no)
AT (1) ATE216269T1 (no)
AU (1) AU717335B2 (no)
BR (1) BR9709690A (no)
CA (1) CA2257902A1 (no)
CZ (1) CZ295227B6 (no)
DE (1) DE69712057T2 (no)
DK (1) DK0906127T3 (no)
ES (1) ES2173453T3 (no)
FR (1) FR2749586B1 (no)
HU (1) HU225034B1 (no)
IL (1) IL127281A0 (no)
NO (1) NO315149B1 (no)
PL (1) PL189533B1 (no)
PT (1) PT906127E (no)
RU (1) RU2204417C2 (no)
TR (1) TR199802578T2 (no)
TW (1) TW474826B (no)
WO (1) WO1997047333A1 (no)
ZA (1) ZA975168B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (fr) * 1998-08-27 2001-09-14 Oreal Dispositif aerosol contenant un polycondensat comprenant au moins un motif polyurethanne et/ou polyuree
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
MEP23508A (en) * 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch
JP2006230930A (ja) * 2005-02-28 2006-09-07 Alcare Co Ltd 貼付材
FR2884143B1 (fr) * 2005-04-08 2007-06-22 Millet Innovation Sa Timbre dermique rechargeable
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
RU2011672C1 (ru) * 1992-06-05 1994-04-30 Государственное предприятие "Научно-исследовательский институт синтетического каучука им.акад.С.В.Лебедева" Композиция для липких материалов
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
RU95101185A (ru) * 1995-01-27 1996-12-10 Акционерное общество "Икофлок" Вододисперсионная клеевая композиция

Also Published As

Publication number Publication date
DE69712057T2 (de) 2002-10-02
HUP9903340A2 (hu) 2000-03-28
ATE216269T1 (de) 2002-05-15
CZ410798A3 (cs) 1999-09-15
AU717335B2 (en) 2000-03-23
EP0906127B1 (fr) 2002-04-17
NO315149B1 (no) 2003-07-21
EP0906127A1 (fr) 1999-04-07
DE69712057D1 (de) 2002-05-23
WO1997047333A1 (fr) 1997-12-18
TW474826B (en) 2002-02-01
FR2749586B1 (fr) 1998-08-07
NO985791D0 (no) 1998-12-10
IL127281A0 (en) 1999-09-22
CA2257902A1 (fr) 1997-12-18
HU225034B1 (en) 2006-05-29
HUP9903340A3 (en) 2000-04-28
AU3266097A (en) 1998-01-07
BR9709690A (pt) 1999-08-10
DK0906127T3 (da) 2002-08-05
ES2173453T3 (es) 2002-10-16
PT906127E (pt) 2002-09-30
ZA975168B (en) 1998-07-22
CZ295227B6 (cs) 2005-06-15
AR013580A1 (es) 2001-01-10
CN1110327C (zh) 2003-06-04
RU2204417C2 (ru) 2003-05-20
CN1227503A (zh) 1999-09-01
PL330535A1 (en) 1999-05-24
JP2000514416A (ja) 2000-10-31
PL189533B1 (pl) 2005-08-31
TR199802578T2 (xx) 1999-03-22
FR2749586A1 (fr) 1997-12-12

Similar Documents

Publication Publication Date Title
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AU2109195A (en) Two-component device for the administration of drugs
DK0826673T3 (da) Acetamidderivater, fremgangsmåde til fremstilling deraf og medicinske præparater
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
FI954105A7 (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
HUP0001065A3 (en) Miniature valve, device for filling the reservoir, apparatus for the transdermal administration of medicine, method of manufacturing said valve
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
DK0771788T3 (da) Substituerede sulfonimidamider, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostikum og
FI952115L (fi) Trandermaalinen terapeuttinen menetelmä 17-beta-estradiolin antamiseen ja menetelmä järjestelmän valmistamiseksi
FI942499A7 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
NO985791D0 (no) Enhet for transdermal administrering av trimegeston, fremgangsmÕte for fremstilling av enheten og anvendelse av denne som medikament
AU3170697A (en) Transdermal drug delivery device for the delivery of tropisetron or granisetron
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
DK392288A (da) Human monoklonale antistoffer samt profylaktiske og terapeutiske midler mod infrektioese sygdomme, der indeholder samme som aktiv bestanddel
NO971879D0 (no) Preparat for transdermal administrasjon
AU1494788A (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
NO970682L (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres fremstilling og deres terapeutiske og profylaktiske anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav